Most of those two weeks is not science. It is finding and assembling the data, which is also where most of the AI sold to pharma quietly stalls.
調査・レポート2026年8月30日•1分で読めます
AI in Pharma Faces Data‑Gathering Delays, Not Scientific Limits
A recent note says most of the two‑week deviation investigation time is spent on data collection, not science, highlighting a bottleneck for AI tools in pharma.
PharmaCountryチームがまとめました · 出典： FiercePharma
評価
(0)
(0)
(0)
(0)
(0)
評価を残す